We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

158 hedge funds and large institutions have $320M invested in ANI Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 40

29% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 24

1.68% more ownership

Funds ownership: 54% → 55.68% (+1.7%)

1% more funds holding

Funds holding: 157 → 158 (+1)

16% less capital invested

Capital invested by funds: $379M → $320M (-$59.7M)

85% less call options, than puts

Call options by funds: $2.71M | Put options by funds: $18M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.93%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
62
Reduced
40
Closed
24
Calls
$2.71M
Puts
$18M
Net Calls
-$15.3M
Net Calls Change
-$12.1M

Top Buyers

1
BlackRock
BlackRock
New York
+$63.5M
2
First Manhattan
First Manhattan
New York
+$15.6M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$4.83M
4
KCM
Kennedy Capital Management
Missouri
+$4.61M
5
MP
Mangrove Partners
Connecticut
+$3.28M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$19.6M
2
HVC
Healthcare Value Capital
New Jersey
-$9.09M
3
PRCM
Pine River Capital Management
Minnesota
-$3.06M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$2.71M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$2.67M +$56.1K +1,000 +2%
TAM
27
Third Avenue Management
New York
$2.47M – – –
1CM
28
1492 Capital Management
Wisconsin
$2.16M +$56.7K +1,010 +2%
DIA
29
Dana Investment Advisors
Wisconsin
$2.1M +$676K +12,042 +40%
VRS
30
Virginia Retirement Systems
Virginia
$1.98M +$2.25M +40,000 New
Charles Schwab
31
Charles Schwab
California
$1.93M +$589K +10,489 +37%
RHJA
32
Rice Hall James & Associates
California
$1.6M -$39.3K -700 -2%
PP
33
Paloma Partners
Connecticut
$1.48M +$581K +10,351 +53%
JAM
34
JW Asset Management
Florida
$1.47M – – –
PVI
35
Pura Vida Investments
New York
$1.43M +$147K +2,625 +10%
New York State Teachers Retirement System (NYSTRS)
36
New York State Teachers Retirement System (NYSTRS)
New York
$1.43M -$11.2K -200 -0.7%
HHC
37
Hutchin Hill Capital
New York
$1.31M +$1.49M +26,500 New
LSV Asset Management
38
LSV Asset Management
Illinois
$1.2M -$107K -1,900 -7%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$1.1M +$208K +3,700 +20%
PCM
40
Perkins Capital Management
Minnesota
$1.1M +$1.24M +22,150 New
PI
41
Putnam Investments
Massachusetts
$1.07M -$143K -2,551 -11%
TCIM
42
TIAA CREF Investment Management
New York
$1.07M -$101K -1,790 -8%
IA
43
Icon Advisers
Colorado
$1.02M +$1.16M +20,700 New
Goldman Sachs
44
Goldman Sachs
New York
$1.02M -$169K -3,014 -13%
Citigroup
45
Citigroup
New York
$899K -$288K -5,136 -22%
CEP
46
Chicago Equity Partners
Illinois
$859K +$48.3K +860 +5%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$850K +$393K +6,998 +69%
Morgan Stanley
48
Morgan Stanley
New York
$821K -$692K -12,325 -43%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$796K +$209K +3,725 +30%
ACM
50
Ativo Capital Management
Illinois
$783K – – –
1
2
3 4 5

ANIP Hedge Fund Activity: Q1 2017 in Review

158 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q1 2017, worth a combined $320M — down 16% from $379M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ANIP positions and 24 closed out — a net gain of 7 holders — while 62 added to existing stakes and 40 trimmed.

The largest buyer was BlackRock, adding an estimated $63.5M. The largest seller was Consonance Capital Management, cutting an estimated $19.6M.

  • 158 institutional investors held ANI Pharmaceuticals (ANIP) as of Q1 2017, up from 157 in Q4 2016.
  • Funds reported $320M of ANI Pharmaceuticals stock for Q1 2017, down 16% quarter-over-quarter.
  • 31 funds opened new ANI Pharmaceuticals positions in Q1 2017 and 24 closed out, a net change of +7 holders.
  • The largest ANI Pharmaceuticals buyer in Q1 2017 was BlackRock, an estimated $63.5M added.
  • The largest ANI Pharmaceuticals seller in Q1 2017 was Consonance Capital Management, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2017.